Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.019 AUD | +2.70% |
|
+18.75% | -45.71% |
May. 22 | Chimeric Therapeutics' First-in-Human CHM CDH17 Study Opens for Enrollment; Shares Up 4% | MT |
May. 20 | Chimeric Therapeutics Receives Ethics Approval for CHM CDH17 Phase 1/2 Clinical Trial | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
10.9M | - | - | - | - | - | |
126B | ||||||
118B | ||||||
27.87B | - | |||||
20.95B | - | |||||
16.92B |